Fig. 3
TEM1 and TEM17 cell distribution between r-GPA patients with S. aureus nasal carriage and latent CMV infection. a The circulating percentage of TEM1 and TEM17 cells within the CD4+TEM cell population in peripheral blood of S. aureus-non-carrying r-GPA patients (open squares; n = 35) and carrying r-GPA patients (filled squares; n = 27). b The circulating percentage of CD4+TEM cells within the CD4+ T cell population in peripheral blood, and c the circulating percentage of TEM1 and TEM17 cells within the CD4+TEM cell population in peripheral blood of HC CMV-seronegative (open circles; n = 15), CMV-seropositive (filled circles; n = 21), r-GPA patients CMV-seronegative (open squares; n = 28), and CMV-seropositive (filled squares; n = 33). Horizontal lines represent median percentages. * p < 0.05, ** p < 0.01, and *** p < 0.001. CD cluster of differentiation, CMV cytomegalovirus, HC healthy control, ns not significant, r-GPA GPA patient in remission, S. aureus, Staphylococcus aureus, T EM effector memory T cell